BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36764327)

  • 1. Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study.
    Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinç F; Catak M; Tekin S; Bilen OI; Öztürk BO; Erden EB; Elbuken G; Yavuz HC; Kadioglu P; Cinar N; Kutluturk F; Bayraktaroglu T; Topçu B; Arslan AI; Gucer H; Cihangiroglu G; Topal CS; Ozturk T; Tekin L; Artas G; Akcay E; Gun BD; Altuntas Y
    Horm Metab Res; 2023 May; 55(5):323-332. PubMed ID: 36764327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
    Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
    Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinc F; Catak M; Tekin S; Ozturk BO; Yavuz HC; Kadioglu P; Cinar N; Bayraktaroglu T; Topcu B; Altuntas Y; Elbuken G
    Endocrine; 2024 Mar; 83(3):700-707. PubMed ID: 37736822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
    Yan L; Zhang M; Song Q; Luo Y
    Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
    Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
    Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
    Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors associated with intrathyroid extension of thyroid microcarcinomas.
    Slijepcevic N; Zivaljevic V; Diklic A; Jovanovic M; Oluic B; Paunovic I
    Langenbecks Arch Surg; 2018 Aug; 403(5):615-622. PubMed ID: 29770856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.
    Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Qin Y; Zhang T; Shao L; Zhang P; Zhang H
    Med Sci Monit; 2020 Dec; 26():e927407. PubMed ID: 33351790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
    World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

  • 13. Papillary thyroid microcarcinoma: an over-treated malignancy?
    Wang TS; Goffredo P; Sosa JA; Roman SA
    World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
    Jeon MJ; Kim WG; Kwon H; Kim M; Park S; Oh HS; Han M; Sung TY; Chung KW; Hong SJ; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2017 Jul; 177(1):25-31. PubMed ID: 28432268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer.
    Lin JD
    Med Oncol; 2010 Jun; 27(2):510-8. PubMed ID: 19507072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
    Lee J; Park JH; Lee CR; Chung WY; Park CS
    Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
    Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
    Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
    Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
    Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
    Sun J; Jiang Q; Wang X; Liu W; Wang X
    Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.